Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Other Accumulated Expenses (2016 - 2025)

Historic Other Accumulated Expenses for Aytu Biopharma (AYTU) over the last 9 years, with Q4 2025 value amounting to $2.9 million.

  • Aytu Biopharma's Other Accumulated Expenses fell 5887.73% to $2.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $2.9 million, marking a year-over-year decrease of 5887.73%. This contributed to the annual value of $3.4 million for FY2025, which is 6229.64% down from last year.
  • As of Q4 2025, Aytu Biopharma's Other Accumulated Expenses stood at $2.9 million, which was down 5887.73% from $2.0 million recorded in Q3 2025.
  • Over the past 5 years, Aytu Biopharma's Other Accumulated Expenses peaked at $9.2 million during Q4 2023, and registered a low of $2.0 million during Q3 2025.
  • For the 5-year period, Aytu Biopharma's Other Accumulated Expenses averaged around $6.1 million, with its median value being $7.1 million (2023).
  • Per our database at Business Quant, Aytu Biopharma's Other Accumulated Expenses surged by 61936.94% in 2021 and then crashed by 7506.65% in 2025.
  • Over the past 5 years, Aytu Biopharma's Other Accumulated Expenses (Quarter) stood at $3.2 million in 2021, then surged by 146.86% to $7.8 million in 2022, then increased by 17.91% to $9.2 million in 2023, then fell by 23.04% to $7.1 million in 2024, then plummeted by 58.88% to $2.9 million in 2025.
  • Its last three reported values are $2.9 million in Q4 2025, $2.0 million for Q3 2025, and $3.4 million during Q2 2025.